Wood S, Kuzel T, Shafikhani S
Cells. 2023; 12(1).
PMID: 36611992
PMC: 9818774.
DOI: 10.3390/cells12010199.
Bancsi M, Veltrop M, Bertina R, Thompson J
Infect Immun. 1998; 66(2):448-50.
PMID: 9453594
PMC: 107926.
DOI: 10.1128/IAI.66.2.448-450.1998.
Nicolau D, Freeman C, Nightingale C, Quintiliani R, Coe C, Maderazo E
Infect Immun. 1993; 61(4):1593-5.
PMID: 8454370
PMC: 281409.
DOI: 10.1128/iai.61.4.1593-1595.1993.
Pefanis A, Giamarellou H, Karayiannakos P, Donta I
Antimicrob Agents Chemother. 1993; 37(2):308-13.
PMID: 8452362
PMC: 187658.
DOI: 10.1128/AAC.37.2.308.
Xiong Y, Potel G, Caillon J, Stephant G, Jehl F, Bugnon D
Antimicrob Agents Chemother. 1995; 39(2):496-9.
PMID: 7726520
PMC: 162566.
DOI: 10.1128/AAC.39.2.496.
Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis.
Vazquez G, Archer G
Antimicrob Agents Chemother. 1980; 17(2):280-5.
PMID: 7387148
PMC: 283772.
DOI: 10.1128/AAC.17.2.280.
Effect of nitrogen mustard on natural history of right-sided streptococcal endocarditis in rabbits: role for cellular host defenses.
Yersin B, Glauser M, FREEDMAN L
Infect Immun. 1982; 35(1):320-5.
PMID: 7054124
PMC: 351032.
DOI: 10.1128/iai.35.1.320-325.1982.
Plasmid-determined resistance to serum bactericidal activity: a major outer membrane protein, the traT gene product, is responsible for plasmid-specified serum resistance in Escherichia coli.
Moll A, Manning P, Timmis K
Infect Immun. 1980; 28(2):359-67.
PMID: 6995306
PMC: 550942.
DOI: 10.1128/iai.28.2.359-367.1980.
Effects of immunization and anticoagulation on the development of experimental Escherichia coli endocarditis.
Thorig L, Thompson J, Van Furth R
Infect Immun. 1980; 28(2):325-30.
PMID: 6995305
PMC: 550937.
DOI: 10.1128/iai.28.2.325-330.1980.
Role of granulocytes and monocytes in experimental Escherichia coli endocarditis.
Meddens M, Thompson J, BAUER W, Van Furth R
Infect Immun. 1984; 43(2):491-6.
PMID: 6363288
PMC: 264323.
DOI: 10.1128/iai.43.2.491-496.1984.
Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.
Taylor P
Microbiol Rev. 1983; 47(1):46-83.
PMID: 6343827
PMC: 281561.
DOI: 10.1128/mr.47.1.46-83.1983.
Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.
Bayer A, Norman D, Kim K
Antimicrob Agents Chemother. 1985; 28(6):781-5.
PMID: 3909954
PMC: 180328.
DOI: 10.1128/AAC.28.6.781.
Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production.
Bayer A, Lindsay P, Yih J, Hirano L, Lee D, Blomquist I
Antimicrob Agents Chemother. 1986; 30(4):528-31.
PMID: 3539007
PMC: 176474.
DOI: 10.1128/AAC.30.4.528.
Experimental Escherichia coli endocarditis in rats: roles of serum bactericidal activity and duration of catheter placement.
Yersin B, Glauser M, Guze P, Guze L, FREEDMAN L
Infect Immun. 1988; 56(5):1273-80.
PMID: 3281906
PMC: 259807.
DOI: 10.1128/iai.56.5.1273-1280.1988.
Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
Bayer A, Hirano L, Yih J
Antimicrob Agents Chemother. 1988; 32(2):231-5.
PMID: 3129985
PMC: 172140.
DOI: 10.1128/AAC.32.2.231.
Characterization of impermeability variants of Pseudomonas aeruginosa isolated during unsuccessful therapy of experimental endocarditis.
Bayer A, Norman D, Kim K
Antimicrob Agents Chemother. 1987; 31(1):70-5.
PMID: 3105442
PMC: 174654.
DOI: 10.1128/AAC.31.1.70.
Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.
Strunk R, Gratz J, Maserati R, Scheld W
Antimicrob Agents Chemother. 1985; 28(3):428-32.
PMID: 2934021
PMC: 180267.
DOI: 10.1128/AAC.28.3.428.
LY146032 compared with penicillin G in experimental aortic valve endocarditis caused by group G streptococci.
Bayer A, Yih J, Hirano L
Antimicrob Agents Chemother. 1988; 32(1):141-3.
PMID: 2831811
PMC: 172116.
DOI: 10.1128/AAC.32.1.141.
Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein.
Yeaman M, Puentes S, Norman D, Bayer A
Infect Immun. 1992; 60(3):1202-9.
PMID: 1541535
PMC: 257613.
DOI: 10.1128/iai.60.3.1202-1209.1992.
Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa.
Bayer A, Park S, Ramos M, Nast C, Eftekhar F, Schiller N
Infect Immun. 1992; 60(10):3979-85.
PMID: 1398909
PMC: 257426.
DOI: 10.1128/iai.60.10.3979-3985.1992.